![](/img/cover-not-exists.png)
Phase I–II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints
Winqvist, Maria, Mozaffari, Fariba, Palma, Marzia, Eketorp Sylvan, Sandra, Hansson, Lotta, Mellstedt, Håkan, Österborg, Anders, Lundin, JeanetteVolume:
66
Language:
english
Journal:
Cancer Immunology, Immunotherapy
DOI:
10.1007/s00262-016-1922-6
Date:
January, 2017
File:
PDF, 742 KB
english, 2017